Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Diabetes Medication Recall 2020: More Metformin Recalled For Cancer Fears
08:05pm, Friday, 05'th Jun 2020
More diabetes medication has been recalled for a possible cancer-causing ingredient. Here's what you need to know about the recall.
This week in Other Barks & Bites: a study from Bertelsmann Stiftung shows that China has made great strides in obtaining patents for important tech sectors; the Federal Circuit rules that attorney’s
AMRX or COLL: Which Is the Better Value Stock Right Now?
03:40pm, Wednesday, 03'rd Jun 2020
AMRX vs. COLL: Which Stock Is the Better Value Option?
Diabetes Drug Recall 2020: Another Metformin Medication Recalled Over Cancer Concerns
02:35pm, Tuesday, 02'nd Jun 2020
Another recall has been issued for the diabetes drug Metformin because it may contain a cancer-causing ingredient over the acceptable levels.
New Strong Buy Stocks For May 26th
11:49am, Tuesday, 26'th May 2020
New Strong Buy Stocks For May 26th
The Independent Director of Amneal Pharmaceuticals, Inc. (NYSE:AMRX), Jeffrey George, Just Bought A Few More Shares
02:27pm, Sunday, 17'th May 2020
Even if it's not a huge purchase, we think it was good to see that Jeffrey George, the Independent Director of Amneal...
Amneal (AMRX) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Friday, 15'th May 2020
Amneal (AMRX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Amneal's Shares March Higher, Can It Continue?
11:57am, Friday, 15'th May 2020
As of late, it has definitely been a great time to be an investor in Amneal Pharmaceuticals.
Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Have A Particularly Volatile Share Price?
10:18am, Tuesday, 12'th May 2020
If you're interested in Amneal Pharmaceuticals, Inc. (NYSE:AMRX), then you might want to consider its beta (a measure...
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
07:26am, Tuesday, 12'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power,
on Tuesday.
HIGH
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2020 Earnings Call Transcript
12:00am, Tuesday, 12'th May 2020
Image source: The Motley Fool. Amneal Pharmaceuticals, Inc. (NYSE: AMRX)Q1 2020 Earnings CallMay 11, 2020, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Amneal Pharmaceuticals Inc. (AMRX) CEO Chirag Patel on Q1 2020 Results - Earnings Call Transcript
07:15pm, Monday, 11'th May 2020
Amneal Pharmaceuticals Inc. (NYSE:AMRX) Q1 2020 Earnings Conference Call May 11, 2020 08:30 AM ET Company Participants Tasos Konidaris - SVP and CFO Chirag Pate
Amneal Pharmaceuticals (AMRX) Surpasses Q1 Earnings and Revenue Estimates
03:35pm, Monday, 11'th May 2020
Amneal (AMRX) delivered earnings and revenue surprises of 150.00% and 12.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
